PROG | Abstracts Part 2 (Plain Language)
Showing how Progenity may have found the link to why 30% of the Ulcerative Colitis population does not respond to humira
Search
Brad Mitchell
- Jan 30
- 5 min
PROG | Abstracts Part 1 (Plain Language)
Description of the Abstract that Progenity announced for Tofacitinib. Xljanez. The future looks bright.
764 views0 comments
Brad Mitchell
- Dec 12, 2021
- 7 min
Rani vs Progenity
Optifinancial Newsletter - Knowledge is power - Brad Mitchell This is not financial advice nor recommendations. This is purely our own...
794 views0 comments
Brad Mitchell
- Dec 5, 2021
- 14 min
PROG's 4 horsemen to healthcare | Starts with December data
The future timeline for the adoption of Progenity's products. S-curve uptrend starts this December.
3,492 views0 comments
Brad Mitchell
- Nov 7, 2021
- 12 min
Progenity | PT $25, Buyout $56, no short squeeze or chart analysis, Just Value
Optifinancial Newsletter - Knowledge is power - Brad Mitchell This is not financial advice nor recommendations. This is purely our own...
15,721 views0 comments